Bayer expects around 3% cost for Merck acquisition debt
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Syndicated LoansInvestment Grade Loans

Bayer expects around 3% cost for Merck acquisition debt

Bayer scientist  230x150

German chemical and pharmaceutical company Bayer has mandated three banks for a bridge loan to finance its $14.2bn acquisition of Merck & Co's consumer care business.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article